No description available.

Cette thèse est consacrée à la mise au point d'une machine moléculaire artificielle sous la forme d'un [1]rotaxane, capable de synthétiser différents polymères de façon autonome. Au cours de cette étude, nous avons réalisé la première synthèse hautement diastéréosélective de [1]rotaxanes par la méthode de reconnaissance active catalysée au cuivre(I). Nous avons montré qu'un frein moléculaire est nécessaire pour assurer la stabilité de l'architecture entrelacée. De plus, l'utilisation d'un macrocycle avec une chaine latérale courte est indispensable pour favoriser la synthèse de lassos moléculaires. Enfin, le centre asymétrique du frein moléculaire guide la stéréosélectivité de la réaction. Ceci permet de faire la synthèse stéréodivergente de [1]rotaxanes à partir de macrocycles énantiomériquement purs. La seconde partie du projet concerne et de la processivité potentielle de ce type d'architecture moléculaire. Dans ce cadre, nous avons construit un [2]rotaxane présentant un stoppeur labile et une fonction thiol protégée sur la chaine latérale du macrocycle. La libération contrôlée du thiol induit la formation d'un [1]rotaxane piégé in situ par un nucléophile indiquant le potentiel de cette approche pour la conception de machines moléculaires fonctionnant de façon itérative. / This thesis is devoted to the development of an artificial molecular machine in the form of [1]rotaxane, designed to synthesize different kind of polymers autonomously. During this study, we accomplished the first highly diastereoselective synthesis of [1]rotaxanes by the copper(I)-catalysed active template method. We showed that a molecular brake was necessary to ensure the stability of the interlocked architecture. Moreover, the use of a short lateral chain of the macrocycle is essential to promote the synthesis of molecular lassos. Finally, the asymmetric center of the molecular brake induces the stereoselectivity of the reaction. This allows us to accomplish the stereodivergent synthesis of [1]rotaxanes from enantiomerically pure macrocycles. The second part of this project concerns the study of the potential processivity of this kind of molecular architecture. In this context, we built a [2]rotaxane which has a labile stopper and a protected thiol moiety on the lateral chain of the macrocycle. The controlled release of the thiol leads to the formation of a [1]rotaxane trapped in situ by a nucleophile, showing the potential of this approach for the design of molecular machines working processively.

<p>DNA methylation is an epigenetic modification that is nearly ubiquitous. Eukaryotic DNA methylation contributes to the regulation of gene expression and maintaining genome integrity. In mammals, DNA methylation occurs primarily on the C5 carbon of cytosine in a CpG dinucleotide context and is catalyzed by the DNA methyltransferases, DNMT1, DNMT3A and DNMT3B. While <i>dnmt3a</i> and <i>dnmt3b</i> genes are highly homologous, the enzymes have distinct functions. Some previous reports suggested differences in the enzymatic behavior of DNMT3A and 3B, which could affect their biological roles. The goal of my thesis work was to characterize kinetics mechanisms of DNMT3A and 3B, and to identify the similarities and differences in their catalytic properties that contribute to their distinct biological functions. Given the sequence similarity between the enzymes, we asked whether DNMT3B was kinetically similar to DNMT3A. In a series of experiments designed to distinguish between various kinetics mechanisms, we reported that unlike DNMT3A, DNMT3B methylated tandem CpG on DNA in a processive manner. We also reported that the disruption of the R-D interface, critical for the cooperativity of DNMT3A, had no effect on DNMT3B activity, supporting the non-cooperative mechanism of this enzyme. </p> <p>DNMT3A is frequently mutated in numerous cancers. Acute Myeloid Leukemia (AML) is a malignancy of hematopoietic stem cells in which numerous patients exhibit a high frequency of the heterozygous somatic mutation Arg882His in DNMT3A. Through thorough consensus motif building, we discovered a strong similarity in CpG flanking sequence preference between DNMT3A Arg882His variant and DNMT3B enzyme. Moreover, we found that the variant enzyme has the same kinetics mechanism as DNMT3B, indicating a gain-of-function effect caused by the mutation. This change is significant because the variant enzyme can aberrantly methylate DNMT3B targets in AML cells and effect global gene expression. In particular, given that DNMT3B has been shown to have oncogenic properties, this suggests that the Arg882His variant can acquire similar oncogenic properties and drive AML development.</p> <p>Taken together, my thesis work provides novel insights into the relationship between the biochemical properties and the biological functions of DNMT3A and 3B. </p>